LONDON--(BUSINESS WIRE)--The coagulation testing market is expected to grow by USD 991.28 million during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of COVID ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting the CE Mark. The new cobas t 411 analyzer ...

Sponsored by: Diagnostica Stago, Inc. In clinical laboratory settings, coagulation factor tests are routinely conducted to identify inherited or acquired deficiencies in patients suspected of an ...

LONDON--(BUSINESS WIRE)--The global point-of-care coagulation testing market is poised to grow by USD 1 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request ...

Sponsored by: Diagnostica Stago, Inc. Laboratory testing for coagulation factor deficiencies and inhibitors is important for diagnosing and monitoring inherited and acquired coagulopathies and for ...

Comprehensive portfolio for hospital and reference labs will complement existing products for patient self-testing and point-of-care testing by healthcare professionals INDIANAPOLIS, Oct. 4, 2011 ...

(HealthDay News) — Most routine coagulation tests can be reliably evaluated after storage at room temperature for up to 8 hours after blood collection, according to a study published in the ...

• Repurposed COVID-19 RATs provide an ideal platform for observing differences in blood coagulability. • Random Forest image classification algorithms can facilitate rapid coagulation status ...

Platelet function testing technology will complement Roche's full line of coagulation analyzers targeted for introduction in US and Canada in 2014 The acquisition supports plans Roche announced in ...

Comprehensive portfolio for hospital and reference labs will complement existing products for patient self-testing and point-of-care testing by healthcare professionals INDIANAPOLIS, Oct. 4, 2011 ...